Skip to main content
Andreas Schlitzer
© Volker Lannert / Uni Bonn

News categories: Honors & Funding

Highly Cited Researchers 2022

ImmunoSensation is prominently represented in the “Highly Cited Researchers 2022” ranking

The Bonn Cluster of Excellence ImmunoSensation2 once more is strongly represented in this year’s ranking of highly cited researchers. Prof. Eicke Latz, head of the Institute of Innate Immunity at the University Hospital Bonn, Prof. Andreas Schlitzer, head of the Quantitative Systems Biology group at LIMES Institute of Bonn University as well as Prof. Joachim Schultze, Director Systems Medicine at the DZNE, are among the year’s most influential researchers once more.

The researchers on the list of "Highly Cited Researchers" are among the world's most influential one percent of their scientific field, according to the creators of the ranking. The benchmark is the frequency with which their scientific publications have been cited by other scientists in the last ten years (period from 2011 to 2021). The ranking is published annually by the Web of Science Group and includes around 6,200 scientists in 21 subject categories.

Prof. Eicke Latz is awarded as one of the most influential researchers in the field of immunology for the nineth time in a row. He has been ranked as one of the “highly cited researchers” every single year, since 2014. Prof. Andreas Schlitzer receives the award for the fourth time. He has been ranked as “highly cited researcher” in cross-Field annually, starting 2019. Prof. Joachim Schultze is ranked for the second time. He had been among the “highly cited researchers” in cross-Field in 2021 and this year belongs to the most influential researchers in the field of immunology.

The full list of researchers is published by web of science and can be found at https://clarivate.com/highly-cited-researchers/

Related news

Go-Bio

News categories: Honors & Funding

GO-Bio program supports innovations made in Bonn

Five projects of ImmunoSensation2 members have received funding from the BMBF's GO-Bio initial program to put their innovative research results into practice. The projects are based at the University Hospital Bonn (UKB) and the University of Bonn and will be funded with a maximum of 100,000 euros each in the exploratory phase. The “GO-Bio initial” funding initiative of the Federal Ministry of Education and Research (BMBF) promotes the development of life science research approaches on the way to application.
View entry
Bone2Gene Funding Peter Krawitz

News categories: Honors & Funding

“Bone2Gene” Secures €1 Million Grant

The “Bone2Gene” project of researchers from the University of Bonn and University Hospital Bonn has been awarded funding worth €1,000,000 as part of the Federal Ministry of Education and Research’s GO-Bio initial program. The money is now enabling the team arround ImmunoSensation Member Prof. Peter Krawitz, to progress to the feasibility phase and get its product ready for market launch. “Bone2Gene“ is using artificial intelligence (AI) to make genetic bone conditions known as skeletal dysplasia easier to spot and diagnose.
View entry
W1 female immunity

News categories: Honors & Funding

New junior professorship for female immunity in Bonn

Anchoring gender perspectives in research: with this aim in mind, the Ministry of Culture and Science of the state of North Rhine-Westphalia is promoting gender denomination for professorships. The University of Excellence Bonn is now receiving a new junior professorship for female immunity at the Faculty of Medicine from the programme. The junior professorship is intended to expand the research focus on immunology at the University of Bonn and the University Hospital Bonn (UKB) to include important issues relating to gender and gender-specific aspects in immunology and women's health.
View entry

Back to the news overview